Lee Philina — SEC Form 4 filings
SEC reporting owner CIK 1845080. 9 Form 4 filings on record with FilingPulse; latest filed 2025-07-21.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-14 to 2025-07-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 4 filings — 56,603 shares, $5,228,724 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: sale of 41,913 shares @ $93.19 ($3,905,872) in Blueprint Medicines Corp, filed 2024-08-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Blueprint Medicines Corp (BPMC) | Chief Commercial Officer | 8 | — | 5 legs · 56,603 sh · $5,228,724 | 30 |
| Fusion Pharmaceuticals Inc. (FUSN) | Director | 1 | — | — | 4 |
Form 4 filings — Lee Philina
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-21 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 21,353 · Disposition to issuer (D): 50,165 · Code (U): 13,184 · Disposition to issuer (D): 8,650 (derivative) · Disposition to issuer (D): 6,928 (derivative) · Disposition to issuer (D): 20,669 (derivative) · +2 more | EDGAR |
| 2025-03-07 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 3,733 @ $88.80 | EDGAR |
| 2025-03-04 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 11,000 @ $0 · Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2024-08-07 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 157 @ $36.05 · Option exercise (M): 1,042 @ $51.06 · Option exercise (M): 5,011 @ $81.44 · Option exercise (M): 4,331 @ $43.15 · Option exercise (M): 8,450 @ $54.13 · Option exercise (M): 10,572 @ $61.31 · +9 more | EDGAR |
| 2024-06-04 | 4 | Fusion Pharmaceuticals Inc. (FUSN) | Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 17,000 (derivative) · Disposition to issuer (D): 17,000 (derivative) · Disposition to issuer (D): 17,000 (derivative) | EDGAR |
| 2024-03-15 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 523 @ $8.80 · Option exercise (M): 1,224 @ $15.01 · Sale (S): 6,223 @ $90.55 · Sale (S): 1,800 @ $89.88 | EDGAR |
| 2024-03-11 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 2,934 @ $90.69 | EDGAR |
| 2024-03-06 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 261 @ $1.87 · Option exercise (M): 261 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1845080 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →